|
|||||||||||||||||||||||||||||||
| Poster No. |
Presenter | Title | |
| P-01 | Kouki Matsuda [Kumamoto University, Japan] |
Hybrid Liposomes Promote HIV-1 Infection by Increasing The Cell Membrane Fluidity | |
| P-02 | Shinichiro Hattori [Kumamoto University, Japan] |
HIV-1 infection in a human NK cell-expanded NOJ mouse model | |
| P-03 | Takeo Kuwata [Kumamoto University, Japan] |
Conformational epitope involving V3 and V4 loops is a major target for antibody-mediated neutralization in SIVsmH635-infected macaques | |
| P-04 | Pattaravadee Srikoon [Kumamoto University, Japan] |
Simultaneous NK activities in novel minor subpopulation of primary human NK cells, CD56dimCD16-, following in vitro model stimulation of an HIV-1 infection in NK cells | |
| P-05 | Yasuhiro Maruta [Kumamoto University, Japan] |
Single-chain variable fragment (scFv) of anti-V3 monoclonal antibody efficiently neutralizes HIV-1 in vitro | |
| P-06 | Hiroki Goto [Kumamoto University, Japan] |
Potent antitumor immune response of Vγ9Vδ2 T cells against primary effusion lymphoma | |
| P-07 | Takahiro Sonoda [Kumamoto University, Japan] |
Cross-subtype neutralizing activity of plasma antibodies from patients infected with HIV-1 CRF01_AE | |
| P-08 | Ryusho Kariya [Kumamoto University, Japan] |
HAMLET and BAMLET induces cell death of Primary Effusion Lymphoma | |
| P-09 | Kazuki Tanaka [Kumamoto University, Japan] |
Analysis of Antibodies to CD4-induced epitope on gp120 | |
| P-10 | Kristel Paola Ramírez Valdez [Kumamoto University, Japan] |
Efficient isolation of monoclonal antibodies against HIV-1 from HIV-1 infected patients | |
| P-11 | Yuzhe Yuan [NIHS, Japan] |
Key Structure of the gp120 V3 Loop Responsible for Noncompetitive Resistance to Maraviroc in R5 HIV-1JR-FL | |
| P-12 | Eriko Kudo [Kumamoto University, Japan] |
Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells | |
| P-13 | Chie Hashimoto [Tokyo Medical and Dental University, Japan] |
An artificial gp41-C34 trimer mimetic targeting the membrane fusion mechanism of HIV-1 | |
| P-14 | Manabu Taura [Kumamoto University, Japan] |
Comparative analysis of ER stress response into HIV protease inhibitors: Lopinavir but not Darunavir induces potent ER stress response | |
| P-15 | Haruo Aikawa [Tokyo Medical and Dental University, Japan] |
Structure-activity relationship studies of peptidic HIV integrase inhibitors | |
| P-16 | Manabu Aoki [Kumamoto Health Science University, Japan] |
Novel three HIV-1 protease inhibitors (PIs), GRL-015-11A, GRL-085-11A, and GRL-097-11A, potently inhibit replication of multi-PI resistant HIV-1s | |
| P-17 | Tomofumi Nakamura [Kumamoto University, Japan] |
Evaluating of the multimer formation of HIV-1 integrase and the inhibitor protein-protein interactions using biomolecular fluorescent complementation (BiFC) | |
| P-18 | Daniel J. Sindhikara [Ritsumeikan University, Japan.] |
Preliminary ventures into 3D-RISM-based drug design: Influenza and AIDS | |
| P-19 | Hironori Hayashi [Kumamoto University, Japan] |
The binding properties of darunavir to HIV-1 protease monomer subunit | |
| P-20 | Takamitsu Matsuzawa [University of Yamanashi, Japan] |
4’-Ethynyl-2-Fluoro-2’-Deoxyadenosine, a nucleoside reverse transcriptase inhibitor, completely blocks HIV Infection of Langerhans Cells | |
| P-21 | Pedro Miguel Salcedo-Gómez [Kumamoto University, Japan] |
New prospective HIV-1 protease inhibitors with potent antiviral activity and favorable blood brain barrier penetration | |
| P-22 | Yusuke Nakano [Kumamoto University, Japan] |
Skewed recognition of monomeric form of CCR5 by maraviroc-resistant R5 HIV-1 | |
| P-23 | Masayuki Amano [Kumamoto University, Japan] |
Mechanism of spontaneous degradation observed in the insertion-containing HIV-1 Capsid proteins, and a new attempt to discover small compound which induce HIV-1 Capsid protein degradation | |
| P-24 | Shigeyoshi Harada [NIID, Japan] |
In vitro induction of twelve CD4 mimic small compounds, NBD-556 and its analogues, resistant variants using primary R5 HIV-1 | |
| P-25 | Nobuyo Higashi-Kuwata [Kumamoto University, Japan] |
ltered dynamics of HIVmC dissemination in huPBMC NOJ mice under Raltegravir administration | |
| P-26 | Masateru Hiyoshi [Kumamoto University, Japan] |
A mechanism for HIV-1 transmission from infected macrophages | |
| P-27 | Masayuki Ishige [NIID/Kumamoto University, Japan] |
Analysis of dominantly replicated virus in the acute phase by X4-type and/or R5-type HIV-1 infection in humanized NOD/SCID/Jak3-null mice | |
| P-28 | Takeshi Nishijima [NCGM/Kumamoto University, Japan] |
Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: A pharmacogenetic study | |
| P-29 | Daisuke Mizushima [NCGM, Japan.] |
Preemptive Therapy Prevents Cytomegalovirus End-organ Disease in Treatment-naïve Patients With Advanced HIV-1 Infection in the HAART ERA. | |
| P-30 | Atsuko Hachiya [NCGM, Japan] |
Small-Molecule inhibits HIV-1 replication by targeting interaction with capsid and nuclear import | |
| P-31 | Michihiro Hashimoto [Kumamoto University, Japan] |
Preferential activation of M2-macrophages by HIV-1 Nef is mediated by a serine/threonine kinase TAK1 | |
| P-32 | Chihiro Motozono [Kinki University, Japan] |
HIV-1 immune escape and cross-reactivity profiles of virus-specific cytotoxic T lymphocytes | |
| P-33 | Misao Kuroki [Kumamoto University, Japan] |
The P-body component MOV10 inhibits HIV replication and LINE-1 retrotransposition. | |
| P-34 | Nami Iwamoto [NIID, Japan] |
SIV control by prophylactic vaccination resulting in Gag/Vif-specific CTL induction in the acute phase | |
| P-35 | Mariko Inoue [Kumamoto University, Japan] |
DDX DEAD-box RNA helicase family modulates HIV-1 Rev and Tat function | |
| P-36 | Koji Watanabe [NCGM/Kumamoto University, Japan] |
Cross-clade CTL recognitions for clade B and A/E viruses in A/E virus-infected Japanese individuals | |
| P-37 | Hayato Murakoshi [Kumamoto University, Japan] |
Control of HIV-1 by multiple HIV-1 immunodominant epitope-specific CD8+ T cells in HIV-1-infected Japanese individuals | |
| P-38 | Yutaka Takebe [NIID, Japan / NCAIDS/STD, China] |
The first indication of international dissemination of HIV-1 CRF01_AE strain typical to Men-having-sex-with-men (MSM) in China: Unexpected linkage between epidemic among MSM in China and Japan | |
| P-39 | Nozomi Kuse [Kumamoto University, Japan] |
Distinct HIV-1 Escape Patterns Selected by CTLs with Identical Epitope Specificity | |
| P-40 | Kazuhiko Maeda [Kumamoto University, Japan] |
Mammalian TREX-2 component GANP is involved in HIV-1 mRNA export | |
| P-41 | Madoka Koyanagi [Kumamoto University, Japan] |
The control of HIV-1 by multiple HIV-1 epitope-specific CD8+ T cell responses in HLA-B*35:01-positive subjects infected with the clade B virus | |
| P-42 | Kamini Gounder [University of KwaZulu-Natal., South-Africa] |
Immunodominance patterns and viral evolution in Gag in HLA-B*7 subtype individuals acutely infected with HIV-1 subtype C in Durban, South Africa | |
| P-43 | Xiaoming Sun [Kumamoto University, Japan] |
Dual recognition of HIV-1-infective cells and selection of escape mutant virus by Cytotoxic T cells recognizing overlapping 8-mer and 10-mer Nef peptide | |
| P-44 | Xiaoguang Li [Kumamoto University, Japan] |
Altering capacity of Nef in enhancement of virion infectivity during a clinical course of HIV-1 infection | |
| P-45 | Takayuki Chikata [Kumamoto University, Japan] |
HLA-Associated Viral Polymorphism in Chronically HIV-1-clade B-Infected Japanese Individuals: Analysis of Four-Digit HLA Allele Level | |
| P-46 | Macdonald Reuben Mahiti [Kumamoto University, Japan] |
Modulation of HIV-1 Nef-mediated HLA class I down-regulation activity during disease progression | |
| P-47 | Keiko Sakai [Kumamoto University, Japan] |
The Impact of HLA-Class-I-Mediated Control of HIV-1 in a Japanese Cohort | |
| P-48 | Hasan Md. Zafrul [Kumamoto University, Japan] |
HLA class I-mediated sequence polymorphism in HIV-1 accessory protein Vpu | |
